|
2011 Journal Article Advanced glycation end products are direct modulators of β-cell functionCoughlan, Melinda T., Yap, Felicia Y. T., Tong, David C. K., Andrikopoulos, Sofianos, Gasser, Anna, Thallas-Bonke, Vicki, Webster, Diane E., Miyazaki, Jun-ichi, Kay, Thomas W., Slattery, Robyn M., Kaye, David M., Drew, Brian G., Kingwell, Bronwyn A., Fourlanos, Spiros, Groop, Per-Henrik, Harrison, Leonard C., Knip, Mikael and Forbes, Josephine M. (2011). Advanced glycation end products are direct modulators of β-cell function. Diabetes, 60 (10), 2523-2532. doi: 10.2337/db10-1033 |
|
2011 Journal Article Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in manCoughlan, Melinda T., Patel, Sheila K., Jerums, George, Penfold, Sally A., Nguyen, Tuong-Vi, Sourris, Karly C., Panagiotopoulos, Sianna, Srivastava, Piyush M., Cooper, Mark E., Burrell, Louise M., MacIsaac, Richard J. and Forbes, Josephine M. (2011). Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man. American Journal of Nephrology, 34 (4), 347-355. doi: 10.1159/000331064 |
|
2011 Journal Article The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinaseKrautwald, Martina, Leech, Dale, Horne, Stacey, Steele, Megan L., Forbes, Josephine, Rahmadi, Anton, Griffith, Renate and Muench, Gerald (2011). The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Research, 14 (4), 383-391. doi: 10.1089/rej.2010.1143 |
|
2011 Journal Article Targeted reduction of advanced glycation improves renal function in obesityHarcourt, Brooke E., Sourris, Karly C., Coughlan, Melinda T., Walker, Karen Z., Dougherty, Sonia L., Andrikopoulos, Sofianos, Morley, Amy L., Thallas-Bonke, Vicki, Chand, Vibhasha, Penfold, Sally A., de Courten, Maximilian P. J., Thomas, Merlin C., Kingwell, Bronwyn A., Bierhaus, Angelika, Cooper, Mark E., de Courten, Barbora and Forbes, Josephine M. (2011). Targeted reduction of advanced glycation improves renal function in obesity. Kidney International, 80 (2), 190-198. doi: 10.1038/ki.2011.57 |
|
2011 Journal Article Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetesCoughlan, Melinda T. and Forbes, Josephine M. (2011). Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes. American Journal of Nephrology, 34 (1), 9-17. doi: 10.1159/000328581 |
|
2011 Journal Article Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesForbes, J. M., Söderlund, J., Yap, F. Y. T., Knip, M., Andrikopoulos, S., Ilonen, J., Simell, O., Veijola, R., Sourris, K. C., Coughlan, M. T., Forsblom, C., Slattery, R., Bierhaus, A., Grey, S. T., Wessman, M., Yamamoto, H., Cooper, M. E. and Groop, P.-H. (2011). Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia, 54 (6), 1586-1587. doi: 10.1007/s00125-011-2145-1 |
|
2011 Journal Article Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesForbes, J. M., Soderlund, J., Yap, F. Y. T., Knip, M., Andrikopoulos, S., Ilonen, J., Simell, O., Veijola, R., Sourris, K. C., Coughlan, M. T., Forsblom, C., Slattery, R., Grey, S. T., Wessman, M., Yamamoto, H., Bierhaus, A., Cooper, M. E. and Groop, P.-H. (2011). Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia, 54 (5), 1032-1042. doi: 10.1007/s00125-011-2058-z |
|
2011 Journal Article Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycansMangat, R., Su, J. W., Lambert, J. E., Clandinin, M. T., Wang, Y., Uwiera, R. R., Forbes, J. M., Vine, D. F., Cooper, M. E., Mamo, J. C. and Proctor, S. D. (2011). Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. Diabetic Medicine, 28 (1), 61-72. doi: 10.1111/j.1464-5491.2010.03138.x |
|
2010 Journal Article Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptorSourris, K. C., Morley, A. L., Koitka, A., Samuel, P., Coughlan, M. T., Penfold, S. A., Thomas, M. C., Bierhaus, A., Nawroth, P. P., Yamamoto, H., Allen, T. J., Walther, T., Hussain, T., Cooper, M. E. and Forbes, J. M. (2010). Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia, 53 (11), 2442-2451. doi: 10.1007/s00125-010-1837-2 |
|
2010 Journal Article The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposityHenstridge, Darren C., Forbes, Josephine M., Penfold, Sally A., Formosa, Melissa F., Dougherty, Sonia, Gasser, Anna, de Courten, Maximilian P., Cooper, Mark E., Kingwell, Bronwyn A. and de Courten, Barbora (2010). The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. Metabolism: Clinical and Experimental, 59 (11), 1556-1561. doi: 10.1016/j.metabol.2010.01.027 |
|
2010 Journal Article The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the keyForbes, Josephine M. (2010). The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the key. American Journal of Pathology, 177 (4), 1600-1602. doi: 10.2353/ajpath.2010.100679 |
|
2010 Journal Article The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouseGiunti, Sara, Calkin, Anna C., Forbes, Josephine M., Allen, Terri J., Thomas, Merlin C., Cooper, Mark E. and Jandeleit-Dahm, Karin A. (2010). The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. American Journal of Physiology - Renal Physiology, 299 (3), F528-F535. doi: 10.1152/ajprenal.00127.2010 |
|
2010 Journal Article Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathyPenfold, Sally A., Coughlan, Melinda T., Patel, Sheila K., Srivastava, Piyush M., Sourris, Karly C., Steer, David, Webster, Diane E., Thomas, Merlin C., MacIsaac, Richard J., Jerums, George, Burrell, Louise M., Cooper, Mark E. and Forbes, Josephine M. (2010). Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney International, 78 (3), 287-295. doi: 10.1038/ki.2010.134 |
|
2010 Journal Article ReplyNorman, Paul E., Davis, Wendy A., Coughlan, Melinda T., Forbes, Josephine M., Golledge, Jonathan and Davis, Timothy M. E. (2010). Reply. Journal of Vascular Surgery, 52 (2), 536-536. doi: 10.1016/j.jvs.2010.04.032 |
|
2010 Journal Article Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathyThallas-Bonke, Vicki, Coughlan, Melinda T., Bach, Leon A., Cooper, Mark E. and Forbes, Josephine M. (2010). Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. American Journal of Nephrology, 32 (1), 73-82. doi: 10.1159/000314924 |
|
2010 Journal Article Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthaseSoro-Paavonen, Aino, Zhang, Wei-Zeng, Venardos, Kylie, Coughlan, Melinda T., Harris, Emma, Tong, David C. K., Brasacchio, Daniella, Paavonen, Karri, Chin-Dusting, Jaye, Cooper, Mark E., Kaye, David, Thomas, Merlin C. and Forbes, Josephine M. (2010). Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. Journal of Hypertension, 28 (4), 780-788. doi: 10.1097/HJH.0b013e328335043e |
|
2010 Journal Article Errata: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2002) 51, (3274-3282))Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. A., Jerums, G. and Osicka, T. M. (2010). Errata: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2002) 51, (3274-3282)). Diabetes, 59 (4), 1113-1114. doi: 10.2337/db10-er04a |
|
2010 Journal Article Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathySourris, Karly C., Harcourt, Brooke E., Penfold, Sally A., Yap, Felicia Y. T., Morley, Amy L., Morgan, Philip E., Davies, Michael J., Baker, Scott T., Jerums, George and Forbes, Josephine M. (2010). Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy. Experimental Diabetes Research, 2010 (Art No.: 974681) 974681, 1-9. doi: 10.1155/2010/974681 |
|
2010 Journal Article Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathyTan, Adeline L. Y., Sourris, Karly C., Harcourt, Brooke E., Thallas-Bonke, Vicki, Penfold, Sally, Andrikopoulos, Sofianos, Thomas, Merlin C., O'Brien, Richard C., Bierhaus, Angelika, Cooper, Mark E., Forbes, Josephine M. and Coughlan, Melinda T. (2010). Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. American Journal of Physiology - Renal Physiology, 298 (3), F763-F770. doi: 10.1152/ajprenal.00591.2009 |
|
2009 Journal Article Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men studyNorman, Paul E., Davis, Wendy A., Coughlan, Melinda T., Forbes, Josephine M., Golledge, Jonathan and Davis, Timothy M. E. (2009). Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men study. Journal of Vascular Surgery, 50 (3), 626-631. doi: 10.1016/j.jvs.2009.05.058 |
